CDKN2A and ovarian neoplasm: In general, p16 is negative or weekly positive in most ovarian tumors, including benign and borderline serous tumors, endometrioid, mucinous, clear cell tumors, as well as sex cord and germ cell neoplasms [5,40,41,42,43,44].